Drug | No of isolates | LPA + MGIT R | LPA + MGIT S | LPA R MGIT S | LPA S MGIT R | Sensitivity (%) | Specificity (%) | PPV (%) | NPV (%) | Agreement (%) | K-Value |
---|---|---|---|---|---|---|---|---|---|---|---|
aRIF | 97 | 14 | 73 | 10 | 0 | 100 (76.8–100) | 87.9(78.9–94.1) | 58.3 (43.9–71.5) | 100 | 89.7 | 0.68 |
aINH | 97 | 43 | 51 | 3 | 0 | 100 (91.8–100) | 94.4 (84.6–98.8) | 93.5 (82.7–97.7) | 100 | 96.9 | 0.93 |
aOFL | 90 | 9 | 74 | 7 | 0 | 100 (66.3–100) | 91.4 (83.0–96.4) | 56.2(38.8–72.3) | 100 | 92.2 | 0.68 |
aKAN | 90 | 3 | 85 | 2 | 0 | 100 (29.2–100) | 97.7(91.9–99.7) | 60.0(27.60–85.5) | 100 | 97.8 | 0.74 |
aEMB | 90 | 15 | 58 | 7 | 10 | 60 (38.7–78.9) | 89.2(79.06–95.56) | 68.2(49.8–82.2) | 85.3(78.1–90.4) | 81.1 | 0.54 |